Janus Henderson Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $454M | Sell |
|
|||||
|
2025
Q2 | $401M | Buy |
|
|||||
|
2025
Q1 | $252M | Buy |
|
|||||
|
2024
Q4 | $135M | Buy |
|
|||||
|
2024
Q3 | $123M | Buy |
|
|||||
|
2024
Q2 | $109M | Buy |
|
|||||
|
2024
Q1 | $102M | Buy |
|
|||||
|
2023
Q4 | $46.2M | Sell |
|
|||||
|
2023
Q3 | $30.2M | Buy |
|
|||||
|
2023
Q2 | $748K | Sell |
|
|||||
|
2023
Q1 | $1.73M | Buy |
|
|||||
|
2022
Q4 | $105K | Sell |
|
|||||
|
2022
Q3 | $274K | Buy |
|
|||||
|
2022
Q2 | $128K | Buy |
|
|||||
|
2022
Q1 | $141K | Sell |
|
|||||
|
2021
Q4 | $231K | Sell |
|
|||||
|
2021
Q3 | $124M | Sell |
|
|||||
|
2021
Q2 | $171M | Sell |
|
|||||
|
2021
Q1 | $177M | Buy |
|
|||||
|
2020
Q4 | $127M | Buy |
|
|||||
|
2020
Q3 | $63.5M | Sell |
|
|||||
|
2020
Q2 | $57.6M | Sell |
|
|||||
|
2020
Q1 | $51.8M | Sell |
|
|||||
|
2019
Q4 | $110M | Buy |
|
|||||
|
2019
Q3 | $9.71M | Buy |
|
|||||
|
2019
Q2 | $9.33M | Buy |
|